Announcements Trials

Browse Landscape

Phase

Status

Recruiting 2 Suspended 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Specimen Handling 34 Magnetic Resonance Spectroscopy 22 Biopsy 20 Cyclophosphamide 11 venetoclax 7 Nivolumab 6 Azacitidine 6 pembrolizumab 5 Etoposide 5 Cisplatin 5 Bevacizumab 5 fludarabine phosphate 4 fludarabine 4 Vincristine 4 Taxes 4 Surgical Procedures, Operative 4 Radiotherapy, Intensity-Modulated 4 Radiosurgery 4 Radiation 4 Doxorubicin 4 Cetuximab 4 durvalumab 3 decitabine and cedazuridine drug combination 3 X-Rays 3 Tacrolimus 3 Surveys and Questionnaires 3 Prednisone 3 Platinum 3 Leucovorin 3 Irinotecan 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Riluzole × 1 year × Clear all

NCT03722680 2026-05-20

RILUZOX-01

UNICANCER

Phase 2 Suspended

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡